Health insurance reimburses three new drugs that prevent attacks in (some) migraine patients. “More and more expensive drugs that are actually niche products are coming onto the market. But they weigh on the budget.”
–
How much money the health insurance company (RIZIV) will spend on three new migraine drugs is a well-kept secret. But that erenumab, galcanezumab and fremanezumab will cost the RIZIV what it says…
– .
